Model of a knee

Paradigm activates first Aus site for osteoarthritis drug trials

Paradigm Biopharmaceuticals Ltd has opened its first Australian site as part of a trial to assess…
The Market Online Video

AFT Pharma sets new $300M target after reaching $200M revenue for FY25

AFT Pharmaceuticals Ltd has unveiled its financial results for FY2025, announcing that it has reached a…
The heart inside a skeleton

Nyrada pushes through to third cohort in Phase 1 trial for NYR-BI03

Nyrada Inc has been given the go-ahead to a third cohort in its Phase 1 clinical…
Nasal spray

‘Expansion’ the watchword in Firebrick’s sales-heavy quarter

Firebrick Pharma Ltd has recorded a busy March quarter for 2025, marked by its move into…
Silhouette of a person with a colourful brain

Emyria opens second Empax centre in Perth to meet mental health demand

Emyria Ltd has launched a second Empax clinic in Western Australia, aiming to support patients with…
3D illustration of the human brain

Argenica doses final patients in acute ischaemic stroke trial

Argenica Therapeutics Ltd has taken an important step in completion of its Phase 2 trial to…
A person counting money

Recce to raise $15.8M in trial funds through placement, entitlement offer

Recce Pharmaceuticals Ltd plans to raise $5 million through a Placement to a private investor in…
MRI of brain injury

Study finds Nyrada’s lead drug can prevent secondary brain injury

Nyrada Inc has reported strong results from a collaborative study it has been engaged in regarding…
Human brain neurons

Neurizon finds positive results for lead drug in 3D brain model study

Neurizon Therapeutics Ltd has completed a study together with Tessara Therapeutics on the impact of NUZ-001…